KG
GSK icon

Kilter Group’s GSK GSK Stock Holding History

Kilter Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.2K Buy
480
+245
+104% +$13K 0.01% 240
2026
Q1 		$13K Sell
235
-4
-2% -$217 0.01% 325
2025
Q4 		$11.7K Buy
239
+48
+25% +$2.24K 0.01% 336
2025
Q3 		$8.24K Hold
191
– – ﹤0.01% 357
2025
Q2 		$7.33K Buy
+191
New +$7.3K ﹤0.01% 317

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Kilter Group's GSK Position: Q2 2026 in Review

Kilter Group increased its GSK (GSK) stake by 104% in Q2 2026, buying an estimated $13K and bringing the position to 480 shares worth $25.2K. The position accounts for 0.01% of the portfolio, ranked #240.

Kilter Group first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Kilter Group held 480 shares of GSK worth $25.2K as of Q2 2026.
  • Kilter Group bought 245 GSK shares in Q2 2026, an estimated $13K.
  • GSK made up 0.01% of Kilter Group's portfolio in Q2 2026, its #240 holding.
  • Kilter Group first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.